Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05048706 · ClinicalTrials.gov registry record
SP TLF Versus Ho:YAG Laser
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 62
- Enrollment target
NCT05048706: Completed study, sponsored by University of Rochester.
NCT05048706 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05048706 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
The investigators aim to compare the performance of the Super Pulse Thulium fiber laser (SP TFL) with that of the standard Holmium: Yttrium-Aluminium-Garnet (Ho:YAG) laser. The investigators hypothesize that the electronically-modulated laser diodes, of the TFL offers the most comprehensive and flexible range of laser parameters among laser lithotripters leading to more efficient (4 times more) and effective stone dusting resulting in production of finer dust particles obviating the need for postoperative ureteric stenting which remains a major source of patient discomfort.
Primary Outcome
We plan to assess the direct impact of SP TFL to efficiently dust 10-30mm stones in the upper urinary tract . Metrics include time needed to ablate the stone i.e. ablation speed (stone volume mm3/sec)
Interventions
- DEVICE Laser lithotripsy (SP TLF)
- DEVICE Laser lithotripsy (Ho:YAG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2021-05-10 |
| Est. Completion | 2024-01-01 |
What the finished NCT05048706 record still lists
NCT05048706 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Laser lithotripsy (SP TLF) is the first listed.
NCT05048706 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05048706 about?
NCT05048706 is a clinical study titled "SP TLF Versus Ho:YAG Laser". The investigators aim to compare the performance of the Super Pulse Thulium fiber laser (SP TFL) with that of the standard Holmium: Yttrium-Aluminium-Garnet (Ho:YAG) laser. The investigators hypothesize that the electronically-modulated laser diodes, of the TFL offers the most comprehensive and flex...
What is the current status of trial NCT05048706?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2021-05-10. Estimated completion is 2024-01-01.
What interventions are being tested in trial NCT05048706?
The interventions under investigation include: Laser lithotripsy (SP TLF) (DEVICE), Laser lithotripsy (Ho:YAG) (DEVICE).
Who is sponsoring clinical trial NCT05048706?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI